Literature DB >> 33589745

Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients.

Lei Chen1,2, Ghassan K Abou-Alfa3,4, Bo Zheng1,2, Jing-Feng Liu5, Jian Bai6, Lu-Tao Du7,8, Yun-Song Qian9, Rong Fan10, Xiao-Long Liu5, Lin Wu11, Jin-Lin Hou12, Hong-Yang Wang13,14,15,16.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33589745      PMCID： PMC8089097          DOI： 10.1038/s41422-020-00457-7

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   46.297


× No keyword cloud information.
  10 in total

Review 1.  Hepatocellular Carcinoma.

Authors:  Augusto Villanueva
Journal:  N Engl J Med       Date:  2019-04-11       Impact factor: 91.245

2.  Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.

Authors:  Maneerat Chayanupatkul; Ronald Omino; Sahil Mittal; Jennifer R Kramer; Peter Richardson; Aaron P Thrift; Hashem B El-Serag; Fasiha Kanwal
Journal:  J Hepatol       Date:  2016-09-28       Impact factor: 25.083

3.  Plasma DNA End-Motif Profiling as a Fragmentomic Marker in Cancer, Pregnancy, and Transplantation.

Authors:  Peiyong Jiang; Kun Sun; Wenlei Peng; Suk Hang Cheng; Meng Ni; Philip C Yeung; Macy M S Heung; Tingting Xie; Huimin Shang; Ze Zhou; Rebecca W Y Chan; John Wong; Vincent W S Wong; Liona C Poon; Tak Yeung Leung; W K Jacky Lam; Jason Y K Chan; Henry L Y Chan; K C Allen Chan; Rossa W K Chiu; Y M Dennis Lo
Journal:  Cancer Discov       Date:  2020-02-28       Impact factor: 39.397

Review 4.  Uncovering the role of 5-hydroxymethylcytosine in the epigenome.

Authors:  Miguel R Branco; Gabriella Ficz; Wolf Reik
Journal:  Nat Rev Genet       Date:  2011-11-15       Impact factor: 53.242

5.  Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People.

Authors:  Yuanjie Pang; Christiana Kartsonaki; Iain Turnbull; Yu Guo; Robert Clarke; Yiping Chen; Fiona Bragg; Ling Yang; Zheng Bian; Iona Y Millwood; Juanzhi Hao; Xianyong Han; Yajing Zang; Junshi Chen; Liming Li; Michael V Holmes; Zhengming Chen
Journal:  Hepatology       Date:  2018-10       Impact factor: 17.425

6.  Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer.

Authors:  Morten Lapin; Satu Oltedal; Kjersti Tjensvoll; Tove Buhl; Rune Smaaland; Herish Garresori; Milind Javle; Nils Idar Glenjen; Bente Kristin Abelseth; Bjørnar Gilje; Oddmund Nordgård
Journal:  J Transl Med       Date:  2018-11-06       Impact factor: 5.531

7.  Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma.

Authors:  Yoshiyuki Yamamoto; Motohide Uemura; Masashi Fujita; Kazuhiro Maejima; Yoko Koh; Makoto Matsushita; Kosuke Nakano; Yujiro Hayashi; Cong Wang; Yu Ishizuya; Toshiro Kinouchi; Takuji Hayashi; Kyosuke Matsuzaki; Kentaro Jingushi; Taigo Kato; Atsunari Kawashima; Takeshi Ujike; Akira Nagahara; Kazutoshi Fujita; Ryoichi Imamura; Hidewaki Nakagawa; Norio Nonomura
Journal:  Cancer Sci       Date:  2019-01-25       Impact factor: 6.716

8.  Genome-wide cell-free DNA fragmentation in patients with cancer.

Authors:  Stephen Cristiano; Alessandro Leal; Jillian Phallen; Jacob Fiksel; Vilmos Adleff; Daniel C Bruhm; Sarah Østrup Jensen; Jamie E Medina; Carolyn Hruban; James R White; Doreen N Palsgrove; Noushin Niknafs; Valsamo Anagnostou; Patrick Forde; Jarushka Naidoo; Kristen Marrone; Julie Brahmer; Brian D Woodward; Hatim Husain; Karlijn L van Rooijen; Mai-Britt Worm Ørntoft; Anders Husted Madsen; Cornelis J H van de Velde; Marcel Verheij; Annemieke Cats; Cornelis J A Punt; Geraldine R Vink; Nicole C T van Grieken; Miriam Koopman; Remond J A Fijneman; Julia S Johansen; Hans Jørgen Nielsen; Gerrit A Meijer; Claus Lindbjerg Andersen; Robert B Scharpf; Victor E Velculescu
Journal:  Nature       Date:  2019-05-29       Impact factor: 49.962

9.  Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.

Authors:  Jiabin Cai; Lei Chen; Zhou Zhang; Xinyu Zhang; Chuan He; Hongyang Wang; Wei Zhang; Jia Fan; Xingyu Lu; Weiwei Liu; Guoming Shi; Yang Ge; Pingting Gao; Yuan Yang; Aiwu Ke; Linlin Xiao; Ruizhao Dong; Yanjing Zhu; Xuan Yang; Jiefei Wang; Tongyu Zhu; Deping Yang; Xiaowu Huang; Chengjun Sui; Shuangjian Qiu; Feng Shen; Huichuan Sun; Weiping Zhou; Jian Zhou; Ji Nie; Chang Zeng; Emily Kunce Stroup; Xu Zhang; Brian C-H Chiu; Wan Yee Lau
Journal:  Gut       Date:  2019-07-29       Impact factor: 31.793

10.  NucMap: a database of genome-wide nucleosome positioning map across species.

Authors:  Yongbing Zhao; Jinyue Wang; Fang Liang; Yanxia Liu; Qi Wang; Hao Zhang; Meiye Jiang; Zhewen Zhang; Wenming Zhao; Yiming Bao; Zhang Zhang; Jiayan Wu; Yan W Asmann; Rujiao Li; Jingfa Xiao
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971
  10 in total
  10 in total

Review 1.  Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.

Authors:  Philip Johnson; Qing Zhou; Doan Y Dao; Y M Dennis Lo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-06-08       Impact factor: 73.082

Review 2.  Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy.

Authors:  Shicai Liu; Jinke Wang
Journal:  Curr Issues Mol Biol       Date:  2022-06-10       Impact factor: 2.976

3.  Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection.

Authors:  Hua Bao; Zheng Wang; Xiaoji Ma; Wei Guo; Xiangyu Zhang; Wanxiangfu Tang; Xin Chen; Xinyu Wang; Yikuan Chen; Shaobo Mo; Naixin Liang; Qianli Ma; Shuyu Wu; Xiuxiu Xu; Shuang Chang; Yulin Wei; Xian Zhang; Hairong Bao; Rui Liu; Shanshan Yang; Ya Jiang; Xue Wu; Yaqi Li; Long Zhang; Fengwei Tan; Qi Xue; Fangqi Liu; Sanjun Cai; Shugeng Gao; Junjie Peng; Jian Zhou; Yang Shao
Journal:  Mol Cancer       Date:  2022-06-11       Impact factor: 41.444

Review 4.  Circulating cell-free DNA for cancer early detection.

Authors:  Qiang Gao; Qiang Zeng; Zhijie Wang; Chengcheng Li; Yu Xu; Peng Cui; Xin Zhu; Huafei Lu; Guoqiang Wang; Shangli Cai; Jie Wang; Jia Fan
Journal:  Innovation (Camb)       Date:  2022-05-06

Review 5.  Circulating Virus-Host Chimera DNAs in the Clinical Monitoring of Virus-Related Cancers.

Authors:  Chiao-Ling Li; Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Cancers (Basel)       Date:  2022-05-20       Impact factor: 6.575

Review 6.  Current and Emerging Tools for Hepatocellular Carcinoma Surveillance.

Authors:  Nia Adeniji; Renumathy Dhanasekaran
Journal:  Hepatol Commun       Date:  2021-09-17

Review 7.  Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma.

Authors:  Jin-Cui Yang; Jun-Jie Hu; Yi-Xin Li; Wei Luo; Jin-Zhou Liu; Da-Wei Ye
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

Review 8.  Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma.

Authors:  Xueying Lyu; Yu-Man Tsui; Daniel Wai-Hung Ho; Irene Oi-Lin Ng
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-02-17

Review 9.  The Application of Liquid Biopsy Techniques in High-Risk Population for Hepatocellular Carcinoma.

Authors:  Jingnuo Ding; Weifeng Zhao
Journal:  Cancer Manag Res       Date:  2022-09-15       Impact factor: 3.602

Review 10.  Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic Target.

Authors:  Takashi Motomura; Sriram Amirneni; Ricardo Diaz-Aragon; Lanuza A P Faccioli; Michelle R Malizio; Michael C Coard; Zehra N Kocas-Kilicarslan; Carla Frau; Nils Haep; Alina Ostrowska; Rodrigo M Florentino; Alejandro Soto-Gutierrez
Journal:  J Pers Med       Date:  2021-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.